Clinical trials
Phase 3 Carcinoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 5 |
| Terminated | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Exelixis | 2 |
| Novartis Pharmaceuticals | 2 |
| Abbott | 1 |
| Ariad Pharmaceuticals | 1 |
| Bayer | 1 |
| Daiichi Sankyo | 1 |
| Hoffmann-La Roche | 1 |
| Ipsen | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 17 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Lung Neoplasms | 6 |
| Neoplasms | 6 |
| Adenocarcinoma | 3 |
| Carcinoma, Hepatocellular | 3 |
| Neoplasms by Site | 3 |
| Carcinoma, Renal Cell | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms by Histologic Type | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.